Oragenics

Oragenics is biopharmaceutical company. Its aim is to develop products through human proof-of-concept prior to partnering with major pharmaceutical, biotechnology or health care product firms for advanced clinical development and commercialization. It has developed a number of products, including replacement therapy, which is a single, painless topical treatment that offers protection from tooth decay; Mutacin 1140 is an antibiotic with activity against Gram-positive bacteria; oral probiotic technology, which employs naturally occurring beneficial bacteria to promote dental and periodontal health; in vivo-induced antigen technology, which provides a method for identification of new targets f